Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04501757
Title Naxitamab and GM-CSF in People With Neuroblastoma
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

neuroblastoma

Therapies

Naxitamab + Sargramostim

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.